{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T19:26:35Z","timestamp":1764617195932,"version":"3.46.0"},"reference-count":51,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.1080\/14737175.2025.2564708","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:20:11Z","timestamp":1759209611000},"page":"1385-1398","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating clazosentan sodium for the treatment of aneurysmal subarachnoid hemorrhage"],"prefix":"10.1080","volume":"25","author":[{"given":"Nived","family":"Jayaraj Ranjini","sequence":"first","affiliation":[{"name":"University of Missouri","place":["Columbia, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran A.","family":"Zahoor","sequence":"additional","affiliation":[{"name":"University of Missouri","place":["Columbia, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pashmeen","family":"Lakhani","sequence":"additional","affiliation":[{"name":"Zeenat Qureshi Stroke Institute","place":["Columbia, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose I.","family":"Suarez","sequence":"additional","affiliation":[{"name":"The Johns Hopkins University School of Medicine","place":["Baltimore, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan I.","family":"Qureshi","sequence":"additional","affiliation":[{"name":"University of Missouri","place":["Columbia, USA"]},{"name":"Zeenat Qureshi Stroke Institute","place":["Columbia, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00266-7"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(94)00080-M"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021845"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1998.tb02337.x"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.597914"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198303173081103"},{"key":"e_1_3_6_9_1","volume-title":"Statpearls [Internet]","author":"Das JM","year":"2025","unstructured":"Das JM, Zito PM. Nimodipine. In: Statpearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jan 16]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534870\/"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/JNN.0000000000000625"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01456369"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-015-0230-x"},{"issue":"6","key":"e_1_3_6_13_1","first-page":"1067","article-title":"Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results","volume":"25","author":"Biondi A","year":"2004","unstructured":"Biondi A, Ricciardi GK, Puybasset L, et al. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol. 2004 Jun;25(6):1067\u20131076.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1005"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.3171\/2025.1.JNS242509"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S468549"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/365759a0"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)37130-7"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-006-0117-z"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.628956"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270007307337"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200727110-00006"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.5414\/CPP47169"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12639"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2005.103.1.0009"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-007-1249-3"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.519942"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.648980"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.3171\/2013.3.JNS121436"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000432"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000475824"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.04.222"},{"key":"e_1_3_6_33_1","unstructured":"Clazosentan for improvement of time to peak perfusion in patients with angiographically confirmed severe vasospasm - PubMed [internet]. [cited 2025 Jan 14]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34296399\/"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.3171\/2022.2.JNS212914"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.035699"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2024.06.019"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-024-03173-7"},{"key":"e_1_3_6_38_1","unstructured":"Mayer SA Bruder N Citerio G et al. React: a randomized trial to assess the efficacy and safety of Clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. 2024 Aug 9 [cited 2025 Jan 15]. Available from: https:\/\/thejns.org\/view\/journals\/j-neurosurg\/142\/1\/article-p98.xml"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03804.x"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010368975"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-00485-6"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.04.024"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-211-75718-5_25"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.3340\/jkns.2024.0195"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.2176\/jns-nmc.2024-0204"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.wnsx.2023.100253"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60010185"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-024-02345-9"},{"key":"e_1_3_6_49_1","unstructured":"Idorsia | News archive [Internet]. [cited 2025 Sept 23].Available from: https:\/\/www.idorsia.com\/media\/news\/news-archive.html?page=2&limit=200&filter=&language=en"},{"key":"e_1_3_6_50_1","unstructured":"Sosei group announces marketing approval for PIVLAZTM (clazosentan sodium) 150 mg in South Korea [internet]. BioSpace. 2023 [cited 2025 Jan 14]. Available from: https:\/\/www.biospace.com\/sosei-group-announces-marketing-approval-for-pivlaz-clazosentan-sodium-150-mg-in-south-korea"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-018-0685-0"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000257964.65743.99"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hest.2023.10.006"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2025.2564708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T18:25:15Z","timestamp":1764613515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2025.2564708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,2]]}},"alternative-id":["10.1080\/14737175.2025.2564708"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2025.2564708","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"type":"print","value":"1473-7175"},{"type":"electronic","value":"1744-8360"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-02-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}